List of works - Moran Frenkel-Pinter

A Novel, Sensitive Assay for Behavioral Defects in Parkinson's Disease ModelDrosophila ⬇️

scientific article published on July 25, 2012

A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)

scientific article

Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model Drosophila

scientific article published on 3 May 2017

Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity

scientific article

Cutting in-line with iron: ribosomal function and non-oxidative RNA cleavage

scientific article published on 14 July 2020

Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegeneration

scientific article published on 14 September 2020

Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract ⬇️

scientific article published on May 2, 2012

Distinct Effects of O-GlcNAcylation and Phosphorylation of a Tau-Derived Amyloid Peptide on Aggregation of the Native Peptide

scientific article published on 24 August 2018

Enhanced bioavailability of polyaromatic hydrocarbons in the form of mucin complexes.

scientific article published on 18 February 2011

Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies

scientific article

Inhibition of the Aggregation and Toxicity of the Minimal Amyloidogenic Fragment of Tau by Its Pro-Substituted Analogues

scientific article published on 23 May 2017

Interplay between protein glycosylation pathways in Alzheimer's disease.

scientific article published on 15 September 2017

Mutually stabilizing interactions between proto-peptides and RNA

scientific article published on 19 June 2020

Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity

scientific article published on 20 January 2016

Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity

scientific article published on 19 February 2019

Prebiotic Peptides: Molecular Hubs in the Origin of Life

scientific article published on 26 February 2020

Root of the Tree: The Significance, Evolution, and Origins of the Ribosome

scientific article published on 06 May 2020

Selective Inhibition of Aggregation and Toxicity of a Tau-Derived Peptide using Its Glycosylated Analogues

scientific article published on 18 February 2016

Selective incorporation of proteinaceous over nonproteinaceous cationic amino acids in model prebiotic oligomerization reactions

scientific article published on 29 July 2019

The pH dependent mechanisms of non-enzymatic peptide bond cleavage reactions

scientific article published on 01 December 2019

Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity

scientific article published on 02 September 2020

List of works by Moran Frenkel-Pinter

A Novel, Sensitive Assay for Behavioral Defects in Parkinson's Disease ModelDrosophila ⬇️

A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)

Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model Drosophila

Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity

Cutting in-line with iron: ribosomal function and non-oxidative RNA cleavage

Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegeneration

Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract ⬇️

Distinct Effects of O-GlcNAcylation and Phosphorylation of a Tau-Derived Amyloid Peptide on Aggregation of the Native Peptide

Enhanced bioavailability of polyaromatic hydrocarbons in the form of mucin complexes.

Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies

Inhibition of the Aggregation and Toxicity of the Minimal Amyloidogenic Fragment of Tau by Its Pro-Substituted Analogues

Interplay between protein glycosylation pathways in Alzheimer's disease.

Mutually stabilizing interactions between proto-peptides and RNA

Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity

Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity

Prebiotic Peptides: Molecular Hubs in the Origin of Life

Root of the Tree: The Significance, Evolution, and Origins of the Ribosome

Selective Inhibition of Aggregation and Toxicity of a Tau-Derived Peptide using Its Glycosylated Analogues

Selective incorporation of proteinaceous over nonproteinaceous cationic amino acids in model prebiotic oligomerization reactions

The pH dependent mechanisms of non-enzymatic peptide bond cleavage reactions

Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity